Business

Aluf Holdings, Inc. Welcomes Dr. Matthew Leftwich CTO and COO to the Board and Announces Strategic Acquisition of Nanomatronix, LLC

Aluf Holdings, Inc. Welcomes Dr. Matthew Leftwich CTO and COO to the Board and Announces Strategic Acquisition of Nanomatronix, LLC.

articleAluf Holdings, Inc.September 17, 20244/company/aluf-holdings-inc/news/aluf-holdings-inc-welcomes-dr-matthew-leftwich-cto-and-coo-to-the-board-and-announces-strategic-acquisition-of-nanomatronix-llc
Aluf Holdings, Inc. Welcomes Dr. Matthew Leftwich CTO and COO to the Board and Announces Strategic Acquisition of Nanomatronix, LLC

About this update from Aluf Holdings, Inc.

[{"type":"text","content":"FORT LAUDERDALE, FL / ACCESSWIRE / September 17, 2024 / Aluf Holdings, Inc. (OTC PINK:AHIX) is thrilled to announce that Dr. Matthew Leftwich, recently appointed as the company's Chief Technology Officer (CTO) and Chief Operations Officer (COO), has been unanimously elected to its Board of Directors. With over 25 years of experience leading high-tech startups, Dr. Leftwich has been instrumental in pioneering cutting-edge technologies. He currently serves as CEO and Engineering Director at Nanomatronix, LLC (NMX), and has previously held key roles as COO at Space Photonics, Inc., as well as Director of the Materials Science and Engineering Graduate Program at the University of Arkansas. Dr. Leftwich will continue to lead NMX while taking on his new responsibilities at Aluf.Commenting on his new role, Dr. Leftwich said, "Aluf is fostering an exceptional culture, and the timing is perfect to integrate and expand NMX's technologies and services into critical markets. Our partnership and upcoming merger with Aluf will accelerate technology development and enable rapid transition into relevant industries, creating sustainable value for our customers and stakeholders."Dr. Leftwich holds a Ph.D. in Microelectronics-Photonics, an MBA, an MS in Engineering Sciences, and a BS in Chemical Engineering.Pending Acquisition of Nanomatronix, LLC:Aluf Holdings has signed a purchase agreement to acquire NMX, with the deal expected to close by early 2025. Dr. Leftwich will play a key role in merging and expanding the research and development (R&D) and technology transfer strategies of both companies. The primary R&D operations will be based in Fayetteville, AR. Upon completion of the acquisition, NMX will become a wholly owned subsidiary of Aluf Holdings, Inc., maintaining its status as a US-based, 100% US-owned, and US-sourced small business.About Aluf Holdings, Inc.:Aluf Holdings, Inc. is a publicly traded company dedicated to acquiring, developing, and managing a diverse portfolio of high-growth potential companies and technologies. With a strong focus on the biotech and biometrics industries, Aluf aims to revolutionize these sectors through innovative solutions and strategic acquisitions.About Nanomatronix, LLC:Nanomatronix, LLC (NMX) is a US-based small business specializing in 100% US-sourced technology development. The comp...

More updates from Aluf Holdings, Inc.